Effect of hypoxia-inducible factor-1α induction by CoCl 2 on breast cancer cells survival: influence of cytochrome-c and survivin

  • Reni Paramita Doctoral student in Biomedical Study, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Mohamad Sadikin Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Noorwati Sutandyo Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Septelia I. Wanandi Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitas Indonesia, Jakarta
DOI: https://doi.org/10.13181/mji.v23i3.933
Keywords: apoptosis, cell viability, cytochrome-c, hypoxia-inducible factor-1α, survivin
Abstract viewed: 1004 times
PDF downloaded: 862 times

Abstract

Background: Tumor tissue usually became hypoxic due to disruption of oxygen supply. Adaptation response to hypoxia is mediated by transcription factor, hypoxia- inducible factor-1α (HIF-1α). HIF-1α signaling is known to increase the expression of pro-apoptotic protein cytochrome-c, and anti- apoptotic survivin. In this study we wanted to analyze the role of HIF-1α on breast cancer cells survival through pro-apoptosis cytohrome-c and anti-apoptosis survivin regulation.

Methods: Breast cancer cell lines T47D were induced by CoCl 2 then harvested to analyze the expression of HIF-1α, protein cytochrome-c, mRNA survivin and cell viabilities

Results: HIF-1α induction by CoCl2 causes the increase of protein and mRNA of HIF-1α, cytochrome-c protein, and survivin mRNA, but does not cause the changes in cell viability.

Conclusion: HIF-1α induction have no effects on breast cancer cell line T47D viabilities due to the balance regulation between pro-apoptosis expression cytochrome-c and anti-apoptosis survivin.

References

  1. International Agency for Research on Cancer (IARC) [Internet]. Breast Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. World Health Organization 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

  2. Okazaki T, Ebihara S, Asada M, Yamanda S, Niu K, Arai H. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival tumor-bearing mice by enhancing angiogenesis. Neoplasia. 2008;10(9):932-9.

  3. Hill R, Bristow RG. The scientific basis of radiotherapy. In: Tannock IF, Hill RP, Bristow RG, Harrington L, editors. The basic science of oncology. 4th ed. Boston: Mc Graw Hill; 2005. p. 298.

  4. Patel SA, Simon MC. Biology of hypoxia-inducible factor-2α in development and disease. Cell Death Differ. 2008;15(4):628-34. http://dx.doi.org/10.1038/cdd.2008.17

  5. Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res. 2006;71(4):642-51. http://dx.doi.org/10.1016/j.cardiores.2006.05.005

  6. Mole DR. Iron homesotasis and its interaction with prolyl hydroxylases. Antioxid Redox Signal. 2010;12(4):445-58. http://dx.doi.org/10.1089/ars.2009.2790

  7. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 2006;70(5):1469-80. http://dx.doi.org/10.1124/mol.106.027029

  8. Ardyanto TD, Osaki M, Nagahama Y, Yamaga K, Maeta N, Tamura T, et al. Down-regulation of cobalt-induced HIF-1α expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells. Oncol Report. 2008;19(2):339-43.

  9. Greijer AE, van der Wal E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004;57(10):1009-14. http://dx.doi.org/10.1136/jcp.2003.015032

  10. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 2008;14(16):5000-5. http://dx.doi.org/10.1158/1078-0432.CCR-08-0746

  11. Peng X, Karna P, Cao Z, Jiang B, Zhou M, Yang L. Cross-talk between epidermal growth factor receptor and HIF-1 signal pathways increases resistance to apoptosis by upregulating survivin gene expression. J Biol Chem. 2006;281(36):25903-14. http://dx.doi.org/10.1074/jbc.M603414200

  12. Li F and Ling X. Survivin study: an update of 'what is the next wave'? J Cell Physiol. 2006;208(3):476-86. http://dx.doi.org/10.1002/jcp.20634

  13. Maxwell P, Salnikow K. HIF-1: An oxygen and metal responsive transcription factor. Cancer Biol Ther. 2004;3(1):29-35. http://dx.doi.org/10.4161/cbt.3.1.547

  14. Aulia G. Modulasi stress oksidatif pada ketahanan hidup sel punca kanker payudara (CD24-/CD44+) melalui induksi rotenone: tinjauan pada ekspresi manganese superoxide dismutase [tesis]. Jakarta: Universitas Indonesia; 2012. Indonesian.

  15. Hendrawan S, Jusman SWA, Ferdinal F, Prijanti AR, Wanandi SI, Sadikin M. Expression of hypoxia inducible factor-1α (HIF-1α) gene and apoptosis in the heart induced by systemic hypoxia. Med J Indones. 2009;18(2):97-101. http://dx.doi.org/10.13181/mji.v18i2.344

  16. Ardyanto TD, Osaki M, Tokuyasu N, Nagahama Y, Ito H. CoCl2-induced HIF-1α expression correlates with proliferation and apoptosis in MKN-1 cells: A possible role for the PI3K/Akt pathway. Int J Oncol. 2006;29(3):549-55.

  17. Kothari S, Cizeau J, McMillan-Ward E, Israels SJ, Bailes M, Ens K, et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene 2003;22(30):4734-44. http://dx.doi.org/10.1038/sj.onc.1206666

  18. Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008;266(1):12-20. http://dx.doi.org/10.1016/j.canlet.2008.02.028

  19. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6(1):127-34.

  20. Wu XY, Fu ZX, Wang XH. Effect of hypoxia-inducible factor 1-α on Survivin in colorectal cancer. Mol Med Rep. 2010;3(3):409-15.

  21. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst. 2001;93(20):1541-52. http://dx.doi.org/10.1093/jnci/93.20.1541

  22. Brizel DM. Chemical modifiers of radiation response. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed. Philadelphia: Lippincott-Raven Publisher; 2008. p. 611-19.

  23. Sekarutami SM. Pengaruh hipksia terhadap angiogenesis dan proliferasi sel kanker serviks uteri: hubungannya dengan respon tumor terhadap kombinasi radiasi dengan karbogen-nikotinamdi (KON) sebagai hypoxia modifier [disertasi]. Jakarta: Universitas Indonesia; 2010. Indonesian.

Published
2014-10-15
How to Cite
1.
Paramita R, Sadikin M, Sutandyo N, Wanandi SI. Effect of hypoxia-inducible factor-1α induction by CoCl 2 on breast cancer cells survival: influence of cytochrome-c and survivin. Med J Indones [Internet]. 2014Oct.15 [cited 2024Apr.26];23(3):139-42. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/933
Issue
Vol. 23 No. 3 (2014): August
Section
Basic Medical Research

Copyright (c) 2014 Reni Paramita, Mohamad Sadikin, Noorwati Sutandyo, Septelia I. Wanandi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.